Routine Screening for Depression in Patients With Coronary Heart Disease. Never Mind

Journal of the American College of Cardiology

Volumn 54, Issue 10, 2009, Pages 886-890

  Ziegelstein, Roy C ^a   Thombs, Brett D ^b   Coyne, James C ^c   de Jonge, Peter ^d,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e TILBURG UNIVERSITY   (Netherlands)

Author keywords

depression; guidelines; screening

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL ENDOCARDITIS; CARDIOVASCULAR RISK; CLINICAL PRACTICE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR DEPRESSION; MEDICAL SOCIETY; PRIORITY JOURNAL; REVIEW; SCREENING; SMOKING; SYMPTOM; SYSTEMATIC REVIEW;

AMERICAN HEART ASSOCIATION; CORONARY DISEASE; DEPRESSION; HUMANS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 68949218472     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.01.082     Document Type: Review

References (31)

1. Lichtman J.H., Bigger Jr. J.T., Blumenthal J.A., et al. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 118 (2008) 1768-1775
2. Fraguas Jr. R., Iosifescu D.V., Alpert J., et al. Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity?. Results from the STAR*D study. Psychosomatics 48 (2007) 418-425
3. Wulsin L.R., and Singal B.M. Do depressive symptoms increase the risk for the onset of coronary disease?. A systematic quantitative review. Psychosom Med 65 (2003) 201-210
4. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 23 (2002) 51-61
5. Musselman D.L., Tomer A., Manatunga A.K., et al. Exaggerated platelet activity in major depression. Am J Psychiatry 153 (1996) 1313-1317
6. Covey L.S., Glassman A.H., and Stetner F. Cigarette smoking and major depression. J Addict Dis 17 (1998) 35-46
7. Allgöwer A., Wardle J., and Steptoe A. Depressive symptoms, social support, and personal health behaviors in young men and women. Health Psychol 20 (2001) 223-227
8. Jokinen J., and Nordström P. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. J Affect Disord 116 (2009) 88-92
9. Sawaya G.F., Guirguis-Blake J., LeFevre M., Harris R., Petitti D., for the U.S., and Preventive Services Task Force. Update on the methods of the U.S. Preventive Services Task Force: Estimating certainty and magnitude of net benefit. Ann Intern Med 147 (2007) 871-875
10. Thombs B.D., de Jonge P., Coyne J.C., et al. Screening for depression and cardiovascular care outcomes: a systematic review. JAMA 300 (2008) 2161-2171
11. Williams Jr. J.W., Pignone M., Ramirez G., and Perez Stellato C. Identifying depression in primary care: a literature synthesis of case-finding instruments. Gen Hosp Psychiatry 24 (2002) 225-237
12. Akincigil A., Bowblis J.R., Levin C., Walkup J.G., Jan S., and Crystal S. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care 45 (2007) 363-369
13. Demyttenaere K., Enzlin P., Dewe W., et al. Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry 62 (2001) 30-33
14. Moride Y., du Fort G.G., Monette J., et al. Suboptimal duration of antidepressant treatments in the older ambulatory population of Quebec: association with selected physician characteristics. J Am Geriatr Soc 50 (2002) 1365-1371
15. Mojtabai R., and Olfson M. National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the National Comorbidity Survey Replication. J Clin Psychiatry 69 (2008) 1064-1074
16. Fernandez A., Haro J.M., Martinez-Alonso M., et al. Treatment adequacy for anxiety and depressive disorders in six European countries. Br J Psychiatry 190 (2007) 172-173
17. Weilburg J.B., O'Leary K.M., Meigs J.B., Hennen J., and Stafford R.S. Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv 54 (2003) 1233-1239
18. Spitzer R.L., Kroenke K., and Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282 (1999) 1737-1744
19. Esposito E., Wang J.L., Adair C.E., et al. Frequency and adequacy of depression treatment in a Canadian population sample. Can J Psychiatry 52 (2007) 780-789
20. Beck C.A., Patten S.B., Williams J.V., et al. Antidepressant utilization in Canada. Soc Psychiatry Psychiatr Epidemiol 40 (2005) 799-807
21. Kessler R.C., Merikangas K.R., and Wang P.S. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol 3 (2007) 137-158
22. Roeloffs C., Sherbourne C., Unutzer J., Fink A., Tang L.Q., and Wells K.B. Stigma and depression among primary care patients. Gen Hosp Psychiatry 25 (2003) 311-315
23. Sirey J.A., Bruce M.L., Alexopoulos G.S., Perlick D.A., Friedman S.J., and Meyers B.S. Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv 52 (2001) 1615-1620
24. Sirey J.A., Bruce M.L., Alexopoulos G.S., et al. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry 158 (2001) 479-481
25. Yarnall K.S.H., Pollak K.I., Ostbye T., Krause K.M., and Michener J.L. Primary care: is there enough time for prevention?. Am J Public Health 93 (2003) 635-641
26. U.S. Preventive Services Task Force. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 147 (2007) 783-786
27. U.S. Preventive Services Task Force. Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 147 (2007) 854-859
28. Wilson W., Taubert K.A., Gewitz M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116 (2007) 1736-1754
29. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 50 (2007) 1707-1732
30. Messerli F.H., and Bangalore S. When guidelines need guidance. Am J Med 121 (2008) 742-743
31. Physician Consortium for Performance Improvement and the Surgical Care Improvement Project of the American Medical Association (2007). http://www.ama-assn.org/ama/pub/category/2946.html Accessed November 10, 2008